​
Login / Signup
Wei Lou
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 2
Top Topics
Combination Therapy
Radical Prostatectomy
Copy Number
Body Weight
Top Venues
Cancer research
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Shu Ning
,
Cameron M Armstrong
,
Enming Xing
,
Amy R Leslie
,
Richard Y Gao
,
Masuda Sharifi
,
Zachary A Schaaf
,
Wei Lou
,
Xiangrui Han
,
Desiree H Xu
,
Rui Yang
,
Jeffrey Cheng
,
Shabber Mohammed
,
Nicholas Mitsiades
,
Chengfei Liu
,
Alan P Lombard
,
Chun-Yi Wu
,
Xiaolin Cheng
,
Pui-Kai Li
,
Allen C Gao
LX1 Targets Androgen Receptor Variants and AKR1C3 to overcome Therapy Resistance in Advanced Prostate Cancer.
Cancer research
(2024)
Shu Ning
,
Chengfei Liu
,
Wei Lou
,
Joy C Yang
,
Alan P Lombard
,
Leandro S D'Abronzo
,
Neelu Batra
,
Ai-Ming Yu
,
Amy R Leslie
,
Masuda Sharifi
,
Christopher P Evans
,
Allen C Gao
Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment.
Molecular cancer therapeutics
21 (10) (2022)